Vasilis Ntziachristos

Vasilis Ntziachristos
EducationAristotle University of Thessaloniki (Diploma)
University of Pennsylvania (MSc, PhD)
Known forOptoacoustic imaging and sensing
AwardsMember of the Leopoldina (2024)
Karl Heinz Beckurts Prize (2021)
ECS Innovation Award, European Union, Horizon Europe Program (2021)
Gold Medal Award of the World Molecular Imaging Society (WMIS, 2015)
DFG Gottfried Wilhelm Leibniz Prize (2013)
Scientific career
FieldsImaging, Microscopy, Optoacoustics, Photonics, Clinical Translation, Computational Methods, Biomedical Engineering, Bioengineering, Machine Learning, Data Analytics
WorkplacesTechnical University of Munich
Helmholtz Munich

Vasilis Ntziachristos is a Greek-American biomedical engineer, scientist and inventor known for developing foundational fluorescence and optoacoustic imaging and sensing technologies for biological and medical applications. He is professor of medicine and electrical engineering at the Technical University of Munich, where he holds the chair of biological imaging.[1] He is also the director of the Institute of Biological and Medical Imaging and the director of bioengineering at Helmholtz Munich.[2][3]

Education

Ntziachristos studied electrical and computer engineering at the Aristotle University of Thessaloniki, earning a diploma degree. He continued his training as a research fellow at the Panum Institute, NMR Center of the University of Copenhagen and as a visiting scholar in radiology at the University of Pennsylvania. He completed an M.Sc. (1998) and a Ph.D. (2000) in bioengineering at the University of Pennsylvania. His doctoral work was carried out under the supervision of Britton Chance, Arjun Yodh and Mitchell Schnall, and focused on integrating magnetic resonance and optical imaging.[4] This work received several distinctions and awards, including the Solomon R. Pollack Awards for Excellence in Graduate Bioengineering Research, from the University of Pennsylvania.

Career

Following his PhD, Ntziachristos joined Harvard Medical School and Massachusetts General Hospital as an instructor in 2001, becoming assistant professor in 2002 and director of the Laboratory for Bio-Optics and Molecular Imaging. In 2007, he was recruited jointly by the Technical University of Munich and Helmholtz Munich to develop biological and medical imaging teaching and research programs,[1][2] where he holds a Full Professor (C4/W3) position.

Leadership and institutional roles

Ntziachristos has held several major leadership positions across European research institutions. He has been an ardent promoter of Bioengineering activities across the Munich academic ecosystem, playing a foundational role at establishing the Munich School of Bioengineering, now known as MIBE, an interdisciplinary research institute at TUM for Bioengineering research and the central research institute for translational cancer research TranslaTUM,[5] where he serves on the board of directors. He has also been a founding member of the Center for Bioengineering at Helmholtz Munich, where he serves as its director and of the Helmholtz Pioneer Campus, a research institute focusing on metabolic health, where he serves as director of bioengineering. Ntziachristos has also served (2023 - 2025) as director of the Institute of Electronic Structure and Laser (IESL) at the Foundation for Research & Technology – Hellas (FORTH), where he spearheaded the foundation of the Center for Quantum Science and Technologies.

Beyond the institutional leadership roles, Ntziachristos has contributed to the establishment and direction of several major research programs at both TUM and Helmholtz Munich, with a focus on advancing bioengineering and biological imaging and sensing technologies across the European research landscape. In the area of scientific publishing, he founded and served as editor-in-chief of Photoacoustics (Elsevier) from 2009 to 2017. Photoacoustics is the only peer-reviewed journal dedicated entirely to photoacoustic / optoacoustic research.[6] He has also served as associate editor for Optics Letters and IEEE Transactions on Medical Imaging. Ntziachristos also plays an active role in shaping research policy and promoting the visibility of optics, photonics and bioengineering, including service in advisory councils for the Greek government, organizing international conferences on biooptics, imaging and articulating a compelling vision of bioengineering as the translation engine for medical applications.[7]

Research

Ntziachristos is an internationally recognized researcher in biomedical imaging. A major focus of his work is on developing fluorescence molecular imaging technologies to support surgical and endoscopic procedures, with the aim of improving cancer detection and clinical outcome. In 2011, he and his collaborators published a translational study in which a targeted fluorescent agent was administered to patients to help distinguish tumor from healthy tissue during surgery.[8][9] This approach is now being validated in several clinical studies. In 2012, Ntziachristos co-founded SurgVision BV, a company developing fluorescence-guided systems for surgery, which was acquired by Bracco Imaging S.p.A. in 2017.[10] More recently his team has demonstrated improved early cancer detection of esophageal cancer compared with white-light microscopy,[11][12] with potential implications for earlier treatment and significant healthcare cost savings.

Another major focus of his research involves the development of optoacoustic imaging technologies designed to offer a breakthrough in optical imaging of tissues and cells. His team works on theoretical and applied development of novel methodologies for non-invasive optoacoustic imaging and sensing and their translation to the benefit of the patient. Among various contributions, he is the inventor of multispectral optoacoustic tomography (MSOT) and raster-scan optoacoustic mesoscopy (RSOM), two non-invasive imaging approaches that enable simultaneous measurement of different physiological and pathological tissue parameters, offering new possibilities for disease early detection and treatment monitoring. MSOT and RSOM have been applied in preclinical and clinical studies examining conditions such as psoriasis,[13] breast tumors,[14] metastatic melanoma,[15] and inflammation in Crohn’s disease,[16] as well as metabolic activity in brown‑fat tissue.[17] Optoacoustic systems based on these technologies are in use in research and clinical environments in various locations worldwide and accounted in 2025 for 55% of all worldwide ongoing optoacoustic studies in humans.[18] Ntziachristos is also the founder of Spear UG, and co-founder of sThesis GmbH and Maurus OY, companies that commercialize optoacoustic technologies.

Other notable developments from his research work include the development of the world’s smallest ultrasound detector,[19] label-free microscopy using mid-infrared optoacoustics,[20] and the development of a next-generation sensor that reads glucose non-invasively from blood, within tissues.[21]

Awards and honours

Ntziachristos has received numerous international awards, including the Gottfried Wilhelm Leibniz Prize (2013),[22] the Gold Medal of the World Molecular Imaging Society (2015),[23] the Karl Heinz Beckurts Prize (2021),[24] the Blaise Pascal International Chair Award (2019),[25] and the GO-Bio Award of the Federal Ministry of Education and Research (Germany).[26] He is the recipient of two ERC Advanced Grants (2008, 2015)[27][28] and ERC PoC Award, the 2014 Germany’s Innovation Prize,[29] the Erwin Schrödinger Prize (2011),[30][31] and was named to the MIT TR100 list of top innovators in 2004.[32] The 2018 anniversary report of the Technical University of Munich features a chapter on Vasilis Ntziachristos, naming him as one of the professors that have shaped the Technical University of Munich. In 2024, he was elected to the German National Academy of Sciences Leopoldina.[33]

References

  1. 1 2 "Chair of Biological Imaging". Technical University of Munich. Retrieved 5 March 2026.
  2. 1 2 "Institute of Biological and Medical Imaging (IBMI)". Helmholtz Munich. Retrieved 5 March 2026.
  3. ↑ "Leadership – Helmholtz Pioneer Campus". Helmholtz Pioneer Campus. Retrieved 5 March 2026.
  4. ↑ "Yodh Lab – People". University of Pennsylvania. Retrieved 5 March 2026.
  5. ↑ "Vasilis Ntziachristos – Biological Imaging". Technical University of Munich. Retrieved 5 March 2026.
  6. ↑ "Photoacoustics – Journal Homepage". Elsevier. Retrieved 5 March 2026.
  7. ↑ Ntziachristos, Vasilis; Quake, Stephen R.; Tschöp, Matthias (2023). "An engineering makeover of biomedical research". Nature Reviews Bioengineering. 1: 154–155. doi:10.1038/s44222-022-00015-3.
  8. ↑ "The Greek Who Makes Cancer Tissues Glow". Ellines. Retrieved 5 March 2026.
  9. ↑ van Dam, Gooitzen M. (2011). "Intraoperative tumor-specific fluorescence imaging of ovarian cancer by folate receptor-α targeting". Nature Medicine. 17 (10): 1315–1319. doi:10.1038/nm.2472.
  10. ↑ "Bracco Imaging acquires SurgVision expanding into the innovative field of fluorescence imaging-guided surgery". PR Newswire. 18 October 2017. Retrieved 29 January 2026.
  11. ↑ Nagengast, Wouter B.; Hartmans, Elmire; Garcia-Allende, Pilar B.; Peters, Frans T. M.; Linssen, Matthijs D.; Koch, Maximilian; Koller, Marjory; Tjalma, Jolien J. J.; Karrenbeld, Arend; Jorritsma-Smit, Annelies; Kleibeuker, Jan H.; van Dam, Gooitzen M.; Ntziachristos, Vasilis (2017). "Near-infrared fluorescence molecular endoscopy detects dysplastic oesophageal lesions using topical and systemic tracer of vascular endothelial growth factor A". Gut. 68 (1): 7–10. doi:10.1136/gutjnl-2017-314953. PMC 6839834. PMID 29247063.
  12. ↑ "ESOTRAC – Hybrid optical and optoacoustic endoscope for esophageal tracking". ESOTRAC Project. European Union Horizon 2020 project. Retrieved 29 January 2026.
  13. ↑ Aguirre, Juan; Schwarz, M.; Soliman, D.; Buehler, A.; Ntziachristos, Vasilis (2017). "Precision assessment of label-free psoriasis biomarkers with ultra-broadband optoacoustic mesoscopy". Nature Biomedical Engineering. doi:10.1038/s41551-017-0068.
  14. ↑ Diot, Gael; Metz, Stephan; Noske, Aurelia; Liapis, Evangelos; Schroeder, Barbara; Ovsepian, Saak V.; Meier, Reinhard; Rummeny, Ernst; Ntziachristos, Vasilis (2017). "Multispectral optoacoustic tomography (MSOT) of human breast cancer". Clinical Cancer Research. 23 (22): 6912–6922. doi:10.1158/1078-0432.CCR-16-3200. PMID 28899968.
  15. ↑ Stoffels, Ingo; Morscher, S.; Helfrich, I.; Hillen, U.; Lehy, C.; Burton, N.; Ntziachristos, Vasilis (2015). "Metastatic status of sentinel lymph nodes in melanoma determined noninvasively with multispectral optoacoustic imaging". Science Translational Medicine. doi:10.1126/scitranslmed.aad1278.
  16. ↑ Knieling, Ferdinand; Neufert, Christoph; Hartmann, Andreas; Clausen, Michael; Neurath, Markus F.; Ntziachristos, Vasilis (2017). "Multispectral optoacoustic tomography for assessment of Crohn's disease activity". New England Journal of Medicine. 376 (13): 1292–1294. doi:10.1056/NEJMc1612455.
  17. ↑ Reber, Josefine; Willershäuser, Martin; Karlas, Alexander; Paul-Yuan, K.; Diot, Gael; Franz, Dieter; Ntziachristos, Vasilis (2018). "Non-invasive measurement of brown fat metabolism based on optoacoustic imaging of hemoglobin gradients". Cell Metabolism. 27 (3): 689–701.e4. doi:10.1016/j.cmet.2018.02.002.
  18. ↑ Ntziachristos, Vasilis (2025). "Addressing unmet clinical need with optoacoustic imaging". Nature Reviews Bioengineering. 3 (3): 182–184. doi:10.1038/s44222-024-00242-w. PMC 12091691.
  19. ↑ Shnaiderman, Rami; Wissmeyer, Georg; Ülgen, Okan; Mustafa, Qutaiba; Chmyrov, Andriy; Ntziachristos, Vasilis (2020). "A submicrometre silicon-on-insulator resonator for ultrasound detection". Nature. 585 (7825): 372–378. doi:10.1038/s41586-020-2685-y. PMID 32939068.
  20. ↑ Pleitez, Miguel A.; von Lilienfeld-Toal, Holger; Månsson, Stefan; Ntziachristos, Vasilis (2020). "Label-free metabolic imaging by mid-infrared optoacoustic microscopy in living cells". Nature Biotechnology. 38 (3): 293–296. doi:10.1038/s41587-019-0359-9.
  21. ↑ Uluç, N. (2024). "Non-invasive measurements of blood glucose levels by time-gating mid-infrared optoacoustic signals". Nature Metabolism. doi:10.1038/s42255-024-01016-9.
  22. ↑ "Gottfried Wilhelm Leibniz-Preis 2013". Deutsche Forschungsgemeinschaft (DFG). Retrieved 29 January 2026.
  23. ↑ "2022 Gold Medal Award Winners". World Molecular Imaging Society. Retrieved 5 March 2026.
  24. ↑ "Karl Heinz Beckurts Prize 2021 for Vasilis Ntziachristos". Helmholtz Munich. Retrieved 22 February 2024.
  25. ↑ "Chaires Blaise Pascal". École normale supérieure. Retrieved 18 December 2018.
  26. ↑ "Licht aus dem Körper hören – nächste Generation der Bildgebung". GO-Bio (BMBF) (in German). Bundesministerium für Bildung und Forschung. 4 October 2009. Retrieved 22 February 2024.
  27. ↑ "ERC Advanced Grant 2008" (PDF). European Research Council. 2008. Archived from the original (PDF) on 4 November 2011. Retrieved 5 March 2026.
  28. ↑ "ERC Advanced Grants 2015 – List of principal investigators" (PDF). European Research Council. Retrieved 5 March 2026.
  29. ↑ "Deutscher Innovationspreis für die iThera Medical GmbH". Helmholtz Zentrum München. Retrieved 18 December 2018.{{cite web}}: CS1 maint: url-status (link)
  30. ↑ "Stifterverband Science Prize – Erwin Schrödinger Prize Awarded". Helmholtz Association. Helmholtz Association of German Research Centres. Retrieved 5 March 2026.
  31. ↑ "The Stifterverband Science Award – Erwin Schrödinger Prize". Helmholtz Association. Helmholtz Association of German Research Centres. Retrieved 5 March 2026.
  32. ↑ "Innovator Under 35: Vasilis Ntziachristos, 34". MIT Technology Review. Massachusetts Institute of Technology. 1 October 2004. Retrieved 5 March 2026.
  33. ↑ "Vasilis Ntziachristos is a new member of the German National Academy of Sciences Leopoldina". Helmholtz Munich. Helmholtz Munich. Retrieved 5 March 2026.

Further reading

This page is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.